WELLINGTON-ALTUS USA INC.’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Hold
683
0.02% 484
2026
Q1
$30.4K Buy
683
+208
+44% +$7.39K 0.02% 438
2025
Q4
$17.1K Buy
+475
New +$17.4K 0.01% 517

Other funds holding VCEL

WELLINGTON-ALTUS USA INC.'s VCEL Position: Q2 2026 in Review

WELLINGTON-ALTUS USA INC. held its Vericel Corp (VCEL) position steady in Q2 2026 at 683 shares worth $22K. The position accounts for 0.02% of the portfolio, ranked #484.

WELLINGTON-ALTUS USA INC. first reported a position in VCEL in Q4 2025 and has held it in 3 quarters since. The position peaked at $30.4K in Q1 2026. 320 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • WELLINGTON-ALTUS USA INC. held 683 shares of Vericel Corp worth $22K as of Q2 2026.
  • WELLINGTON-ALTUS USA INC. left its Vericel Corp share count unchanged in Q2 2026.
  • Vericel Corp made up 0.02% of WELLINGTON-ALTUS USA INC.'s portfolio in Q2 2026, its #484 holding.
  • WELLINGTON-ALTUS USA INC. first reported a position in Vericel Corp in Q4 2025 and has held it in 3 quarters since.
  • WELLINGTON-ALTUS USA INC.'s Vericel Corp position peaked at $30.4K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on WELLINGTON-ALTUS USA INC.'s 13F filing for Q2 2026, filed 17 Sep 2026.